Skip to content

Clinical trials

Hepatitis B trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Country / region: Canada Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20042
20054
20063
20074
20084
20091
20106
20111
20128
20131
20145
20152
20164
20173
20186
20192
20203
20215
20223
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Terminated12
Unknown status7
Active, not recruiting6
Withdrawn4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline16
Gilead Sciences10
University Health Network, Toronto6
Assembly Biosciences5
Bristol-Myers Squibb3
Dynavax Technologies Corporation3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)3
University of British Columbia3
F-star Therapeutics, Inc.2
Laval University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B83
Hepatitis B, Chronic25
Hepatitis13
Hepatitis C7
Hepatitis, Chronic6
Diphtheria5
Poliomyelitis5
Tetanus5
Acquired Immunodeficiency Syndrome4
Haemophilus Infections4

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.